Company Update: SK pharmteco to Expand Capabilities with Acquisition of Controlling Interest in CBM |
Learn More
Search for:
About us
Leadership team
Direction and location
Code of Conduct and Ethics
Our new 5,000 m2 biomanufacturing site
Services
Bioprocess development (USP & DSP)
cGMP manufacturing of clinical & commercial batches
Analytical Development, Qualification & Validation – QC & QA
Fill & Finish
Regulatory Support
Our platforms
LentiSure™: Lentivirus Manufacturing Platform
AAVelocity™: AAV Manufacturing Platform
Innovation
News, blog & events
News
Blog
Events
Careers
Contact us
Search for:
News
All
News
Blog
Events
Yposkesi enters into agreement for strategic partnership to expand Axovant gene therapy manufacturing capacity
28 November 2018
Read more
Yposkesi appoints Dr. Fraser Wright as senior advisor
3 July 2018
Read more
Yposkesi selected by Orchard Therapeutics to produce lentiviral vectors for gene therapies in clinical trials
18 December 2017
Read more
Yposkesi welcomes Alain Lamproye, an industrial bioprocess expert, as CEO
28 February 2017
Read more
AFM-Telethon and Bpifrance create Yposkesi, the first French industrial pharmaceutical company dedicated to producing gene and cell therapy drugs for rare diseases
1 November 2016
Read more
Load more News
Would you like to know more ?
Contact us